892-P: Impact of ReCET Therapy on Continuous Glucose Monitoring (CGM) Metrics in Type 2 Diabetes—Insights from the REGENT-1 TrialDAVID N. O'NEAL, Elif I. Ekinci, Christopher Sorli et al.|Diabetes|2025Cited by 0